Gene · 3980
Papers1,941
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,941
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| To Fix or Not to Fix: Maintenance of Chromosome Ends Versus Repair of DNA Double-Strand Breaks. | Cells | 2022 | 36291091 | PubTator, text mining | PubMed |
| Targeting Mitochondrial Function with Chemoptogenetics. | Biomedicines | 2022 | 36289721 | PubTator, text mining | PubMed |
| Comparison of the Medical Uses and Cellular Effects of High and Low Linear Energy Transfer Radiation. | Toxics | 2022 | 36287908 | PubTator, text mining | PubMed |
| Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors. | J Biomed Sci | 2022 | 36284291 | PubTator, text mining | PubMed |
| Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin. | J Transl Med | 2022 | 36273153 | PubTator, text mining | PubMed |
| Dynamics of the Artemis and DNA-PKcs Complex in the Repair of Double-Strand Breaks. | J Mol Biol | 2022 | 36270581 | PubTator, text mining | PubMed |
| 8-Oxoguanine: from oxidative damage to epigenetic and epitranscriptional modification. | Exp Mol Med | 2022 | 36266447 | PubTator, text mining | PubMed |
| Catalytically inactive DNA ligase IV promotes DNA repair in living cells. | Nucleic Acids Res | 2022 | 36263813 | PubTator, text mining | PubMed |
| Emetine blocks DNA replication via proteosynthesis inhibition not by targeting Okazaki fragments. | Life Sci Alliance | 2022 | 36260751 | PubTator, text mining | PubMed |
| The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment. | J Hematol Oncol | 2022 | 36253861 | PubTator, text mining | PubMed |
| Saccharomyces cerevisiae as a Model System for Eukaryotic Cell Biology, from Cell Cycle Control to DNA Damage Response. | Int J Mol Sci | 2022 | 36232965 | PubTator, text mining | PubMed |
| Mitochondrial DNA Repair in Neurodegenerative Diseases and Ageing. | Int J Mol Sci | 2022 | 36232693 | PubTator, text mining | PubMed |
| Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival. | Cancers (Basel) | 2022 | 36230543 | PubTator, text mining | PubMed |
| Allele-specific differential regulation of monoallelically expressed autosomal genes in the cardiac lineage. | Nat Commun | 2022 | 36216821 | PubTator, text mining | PubMed |
| DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities. | Exp Mol Med | 2022 | 36207426 | PubTator, text mining | PubMed |
| The DNA repair function of BCL11A suppresses senescence and promotes continued proliferation of triple-negative breast cancer cells. | NAR Cancer | 2022 | 36186110 | PubTator, text mining | PubMed |
| Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian cancer. | J Biol Chem | 2022 | 36183837 | PubTator, text mining | PubMed |
| Base excision repair accessory factors in senescence avoidance and resistance to treatments. | Cancer Drug Resist | 2022 | 36176767 | PubTator, text mining | PubMed |
| A New Complex Design of Fe (II) Isoleucine Dithiocarbamate as a Novel Anticancer and Antivirus against SARSCOV-2 (COVID-19). | Asian Pac J Cancer Prev | 2022 | 36172674 | PubTator, text mining | PubMed |
| Proteomic profiling reveals an association between ALDH and oxidative phosphorylation and DNA damage repair pathways in human colon adenocarcinoma stem cells. | Chem Biol Interact | 2022 | 36162455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3980/papers?page=14